Is there a Turkish original version of Midostaurin?

Midostaurin (Midostaurin) is a drug that is a multi-target tyrosine kinase inhibitor. It was developed to treat specific types of hematological tumors, primarily acute myeloid leukemia (AML) and kinase-positive systemic mast cell disease (SM-AHN).

Midostaurin is available as a Turkish original drug. Currently, Midostaurin is not available in China, so patients cannot purchase it domestically. Midostaurin abroad is divided into original drugs and generic drugs. The cheaper original version is the Indian version, which costs more than 10,000 yuan. Others include Turkish and European original drugs, which cost tens of thousands to hundreds of thousands, which are relatively expensive. Generic drugs are mainly Indian generic drugs, which cost about several thousand yuan per box. They are much cheaper than the original drug, and the drug ingredients are basically the same as the original drug.

Midostaurin is indicated for use in newly diagnosed adult AML patients in whom the FLT3 gene mutation is positive for FLT3-ITD (internal duplication) or FLT3-TKD (tyrosine kinase domain). Midostaurin is indicated for adult patients with SM-AHN, especially those carrying the D816V mutation in the KIT gene. Midostaurin may also be used in the treatment of some ascending myeloid tumors, but the specific use depends on the patient's condition and the doctor's judgment.

The specific usage and dosage of midostaurin should be determined according to the doctor's prescription and guidance. Generally, usage involves oral administration and dosage and duration of treatment will vary depending on the patient's specific condition. Patients should strictly abide by the doctor's prescription and take it on time.

Midostaurin, as a targeted therapy drug, has potential therapeutic effects in the treatment of hematological tumors such as AML and SM-AHN. However, the specific therapeutic effect and safety are still affected by the patient's genotype, disease severity and treatment plan, and should be used under the guidance of a doctor. Patients should pay close attention to side effects and communicate regularly with their doctor while using midostaurin to ensure safe treatment.